| Product Information |
DR-XY48834_PI_01.pdf
|
| Registration Number |
DR-XY48834
|
| Generic Name |
Cabotegravir
|
| Brand Name |
Apretude
|
| Dosage Strength |
200 mg/mL (600 mg/3 mL)
|
| Dosage Form |
Prolonged-Release
Suspension for Intramuscular Injection (Gluteal)
|
| Classification |
Prescription Drug (RX)
|
| Pharmacologic Category |
-
|
| Packaging |
3 mL (net content) Type I clear and colorless glass vial with bromobutyl rubber stopper and aluminum seal with orange plastic flip-off cap (box of 1 vial and 25 vials)
|
| Manufacturer |
Glaxo Operations UK Limited
|
| Country of Origin |
United Kingdom
|
| Trader |
ViiV Healthcare UK Limited
|
| Importer |
GlaxoSmithKline Philippines, Inc.
|
| Distributor |
GlaxoSmithKline Philippines, Inc.
|
| Application Type |
Monitored Release
|
| Issuance Date |
03 August 2023
|
| Expiry Date |
03 August 2028
|